Business Context and Reporting Period
This Form 8-K Current Report was filed by Evolent Health, Inc. on September 1, 2015. The filing reports corporate governance changes effective as of September 1, 2015, specifically regarding the composition of the Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel and governance matters rather than financial performance.
Material Changes
- Board Expansion: The Board of Directors increased the number of directors from eight to nine.
- New Appointment: Kenneth A. Samet was appointed as a director.
- Committee Assignment: Mr. Samet was appointed to the Audit Committee, having met NYSE financial literacy and experience requirements.
- Independence: The Board determined Mr. Samet is an independent director under NYSE Corporate Governance Standards and meets SEC independence requirements for the Audit Committee.
Guidance, Outlook, and Management Commentary
The filing contains no financial guidance, outlook, or management commentary regarding future business performance. It notes that Mr. Samet will receive standard director indemnification arrangements and be eligible for compensation programs established for non-employee directors. No unusual items or contingencies were disclosed.
Investor Verification Checklist
- Verify the background and prior roles of Kenneth A. Samet, specifically his tenure as President and CEO of MedStar Health.
- Confirm the updated total number of directors on the Board is nine.
- Review the press release dated September 2, 2015 (Exhibit 99.1) for additional context on the appointment.
- Check subsequent filings for any changes to the Audit Committee composition or independence status.